Cantabio Pharmaceuticals Inc (CTBO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cantabio Pharmaceuticals Inc (CTBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8162
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cantabio Pharmaceuticals Inc (Cantabio Pharmaceuticals) is a biotechnology company that concentrates on the commercializing of novel therapies for Parkinson’s disease, Alzheimer’s disease and neurodegenerative diseases. The company provide pipeline product candidates such as CB101 and CB102, used to treat Parkinson’s disease; CB201 is being developing for the treatment of Parkinson’s disease and Alzheimer’s disease and CB301, is used to treat Alzheimer’s disease. Cantabio Pharmaceuticals conducts in house research and development on critical elements of its drug discovery pipeline by utilizing novel technologies and outsourcing generic research activities to contract research organizations. The company operates in Cambridge, the UK and Budapest, Hungary. Cantabio Pharmaceuticals is headquartered in Sunnyvale, California, the US.

Cantabio Pharmaceuticals Inc (CTBO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cantabio Pharma Partners with University of Antioquia 10
Cantabio Pharma Enters into Drug Discovery Agreement with NovAliX 11
Licensing Agreements 12
Cantabio Pharma Enters into Licensing Agreement with University of Cambridge 12
Cantabio Pharma Enters into Licensing Agreement with Purdue Research Foundation 13
Debt Offering 14
Cantabio Pharma Raises USD0.3 Million in Private Placement of 5% Debentures Due 2019 14
Cantabio Pharma Raises USD0.2 Million in Third and Final Tranche of Private Placement of 5% Debentures Due 2018 15
Cantabio Pharma Raises USD0.2 Million in Second Tranche of Private Placement of 5% Debentures Due 2018 16
Cantabio Pharma Raises USD0.3 Million in First Tranche of Private Placement of 5% Debentures Due 2018 17
Acquisition 18
Gardedam Therapeutics Acquires Cantabio Pharma in Reverse Takeover Transaction 18
Cantabio Pharmaceuticals Inc – Key Competitors 19
Cantabio Pharmaceuticals Inc – Key Employees 20
Cantabio Pharmaceuticals Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Product News 22
Jul 06, 2017: Cantabio Announces Publication of Study Results by University of Cambridge researchers in ACS Chemical Neuroscience 22
07/06/2017: Cantabio Announces Publication of Study Results by University of Cambridge researchers in ACS Chemical Neuroscience 23
02/14/2017: Cantabio Pharmaceuticals to Present Results from Its Tau Protein Targeting Therapeutic Program for the Treatment of Alzheimers Disease at the 13th International Conference on Alzheimer’s and Parkinson’s Disease 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cantabio Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cantabio Pharma Partners with University of Antioquia 10
Cantabio Pharma Enters into Drug Discovery Agreement with NovAliX 11
Cantabio Pharma Enters into Licensing Agreement with University of Cambridge 12
Cantabio Pharma Enters into Licensing Agreement with Purdue Research Foundation 13
Cantabio Pharma Raises USD0.3 Million in Private Placement of 5% Debentures Due 2019 14
Cantabio Pharma Raises USD0.2 Million in Third and Final Tranche of Private Placement of 5% Debentures Due 2018 15
Cantabio Pharma Raises USD0.2 Million in Second Tranche of Private Placement of 5% Debentures Due 2018 16
Cantabio Pharma Raises USD0.3 Million in First Tranche of Private Placement of 5% Debentures Due 2018 17
Gardedam Therapeutics Acquires Cantabio Pharma in Reverse Takeover Transaction 18
Cantabio Pharmaceuticals Inc, Key Competitors 19
Cantabio Pharmaceuticals Inc, Key Employees 20
Cantabio Pharmaceuticals Inc, Other Locations 21

List of Figures
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cantabio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Cantabio Pharmaceuticals Inc (CTBO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gainesville Regional Utilities:企業の戦略的SWOT分析
    Gainesville Regional Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Corporacion Moctezuma, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Corporacion Moctezuma, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Corporacion Moctezuma, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Aker Solutions ASA (AKSO):石油・ガス:M&Aディール及び事業提携情報
    Summary Aker Solutions ASA (Aker Solutions) is a global provider of engineering, design, production systems and services to the oil and gas industry. The company offers subsea production equipment and offshore field design, ranging from concept studies and front-end engineering to subsea production …
  • Tele2 AB (TEL2 B):企業の財務・戦略的SWOT分析
    Tele2 AB (TEL2 B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ALS Limited (ALQ)-石油・ガス分野:企業M&A・提携分析
    Summary ALS Limited (ALS), formerly, Campbell Brothers Limited is a diversified testing service provider. The company provides testing services in the areas of minerals, life sciences, energy and industrial. It provides chemical and laboratory services, technical testing and inspection services supp …
  • Cosmo Oil Co., Ltd.:企業の戦略・SWOT・財務分析
    Cosmo Oil Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cosmo Oil Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • SAS AB:戦略・SWOT・企業財務分析
    SAS AB - Strategy, SWOT and Corporate Finance Report Summary SAS AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Transmissora Alianca de Energia Eletrica SA (TAEE11):企業の財務・戦略的SWOT分析
    Transmissora Alianca de Energia Eletrica SA (TAEE11) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Bombardier Inc:戦略・SWOT・企業財務分析
    Bombardier Inc - Strategy, SWOT and Corporate Finance Report Summary Bombardier Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • ERG SpA (ERG):企業の財務・戦略的SWOT分析
    ERG SpA (ERG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • BlackRock Inc:企業のM&A・事業提携・投資動向
    BlackRock Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BlackRock Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • CG Power and Industrial Solutions Ltd (CGPOWER):企業の財務・戦略的SWOT分析
    CG Power and Industrial Solutions Ltd (CGPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Avid Technology Inc (AVID):企業の財務・戦略的SWOT分析
    Avid Technology Inc (AVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • China Shenhua Energy Co Ltd:戦略・SWOT・企業財務分析
    China Shenhua Energy Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Shenhua Energy Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Response Biomedical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Response Biomedical Corp (Response Biomedical) focuses on the research, development, manufacture and marketing of diagnostic technologies for the point-of-care (POC), central-lab testing and on-site environmental testing markets. It offers Cardiovascular tests such as Troponin-I, Myoglobin, …
  • Limacorporate SpA-医療機器分野:企業M&A・提携分析
    Summary Limacorporate SpA (Lima) is a medical device company that offers reconstructive and fixation orthopaedic solutions. The company offers large joint primary, large joint revision, extremities and fixation and promade products. It offers medical products for knee, hip, shoulder, cups, small joi …
  • Australia and New Zealand Banking Group Ltd:戦略・SWOT・企業財務分析
    Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • J.B. Hunt Transport Services, Inc.:企業の戦略・SWOT・財務分析
    J.B. Hunt Transport Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary J.B. Hunt Transport Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Vivimed Labs Ltd (VIVIMEDLAB):企業の財務・戦略的SWOT分析
    Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Aubert & Duval:企業の戦略・SWOT・財務情報
    Aubert & Duval - Strategy, SWOT and Corporate Finance Report Summary Aubert & Duval - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆